Article
Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy.
Kidney international - 1 Sept 2008
Jorsal Anders, Tarnow Lise, Frystyk Jan, Lajer Maria, Flyvbjerg Allan, Parving Hans-Henrik, Vionnet Nathalie, Rossing Peter
Abstract excerpt
Adiponectin levels are increased in patients with type I diabetes especially in the presence of microangiopathy. Here we determined the predictive value of serum adiponectin levels and 8 adiponectin gene polymorphisms for mortality, cardiovascular events and end-stage renal disease in type I diabetic patients. This prospective, observational follow-up study of type I diabetics consisted of 438 patients with overt...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
